Stem Cell Research & Therapy

tracked for impact factor

Review

Stem cell therapy for retinal diseases: update

Rubens C Siqueira

Author Affiliations

São Paulo University, Ribeirão Preto, Rua Saldanha Marinho 2815 conj 42, São Paulo 15010-100, Brazil

Rubens Siqueira Research Center, Sao Jose do Rio Preto, Rua Saldanha Marinho 2815 conj 42, São Paulo 15010-100, Brazil

Retina Cell, Sao Jose do Rio Preto, Rua Saldanha Marinho 2815 conj 42, São Paulo 15010-100, Brazil

Stem Cell Research & Therapy 2011, 2:50 doi:10.1186/scrt91

Published: 29 December 2011

Abstract

Distinct stem cell types have been established from embryos and identified in the fetal tissues and umbilical cord blood as well as in specific niches in many adult mammalian tissues and organs such as bone marrow, brain, skin, eyes, heart, kidneys, lungs, gastrointestinal tract, pancreas, liver, breast, ovaries, and prostate. All stem cells are undifferentiated cells that exhibit unlimited self-renewal and can generate multiple cell lineages or more restricted progenitor populations that can contribute to tissue homeostasis by replenishing the cells or to tissue regeneration after injury. The remarkable progress of regenerative medicine in the last few years indicates promise for the use of stem cells in the treatment of ophthalmic disorders. Experimental and human studies with intravitreal bone marrow-derived stem cells have begun. This paper reviews recent advances and potential sources of stem cells for cell therapy in retinal diseases.